Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan, Oxidant Stress and Re-Endothelialization Capacity in Chronic Kidney Disease (OECD Study)
2008-003249-10Phase 2Completed
- Sponsor
- Saarland University
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of olmesartan in chronic kidney disease (CKD), sponsored by Saarland University. Primary endpoint: Primary endpoint: Re-endothelialized area after carotid injury. Started Feb 2009; status: completed.
02
Drugs
olmesartan
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2008-003249-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003249-10.